Jan A. Nolta

16.7k total citations · 4 hit papers
233 papers, 11.6k citations indexed

About

Jan A. Nolta is a scholar working on Molecular Biology, Genetics and Genetics. According to data from OpenAlex, Jan A. Nolta has authored 233 papers receiving a total of 11.6k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Molecular Biology, 83 papers in Genetics and 53 papers in Genetics. Recurrent topics in Jan A. Nolta's work include Mesenchymal stem cell research (80 papers), Virus-based gene therapy research (45 papers) and Tissue Engineering and Regenerative Medicine (31 papers). Jan A. Nolta is often cited by papers focused on Mesenchymal stem cell research (80 papers), Virus-based gene therapy research (45 papers) and Tissue Engineering and Regenerative Medicine (31 papers). Jan A. Nolta collaborates with scholars based in United States, China and Canada. Jan A. Nolta's co-authors include Mo A. Dao, Donald B. Kohn, Gerhard Bauer, Louisa Wirthlin, Ping Zhou, Todd E. Meyerrose, David A. Hess, Stefanos Kalomoiris, Daniel C. Link and Ivana Rosová and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nucleic Acids Research.

In The Last Decade

Jan A. Nolta

225 papers receiving 11.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hypoxic Preconditioning Results in Increased Motility and Improved Therapeutic Potential of Human Mesenchymal Stem Cells

2008 560 citations Ivana Rosová, Mo A. Dao et al. Stem Cells profile →
Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature

2019 542 citations Sowmya Viswanathan, Yufang Shi et al. Cytotherapy profile →
Generation of human vascularized brain organoids

2018 398 citations Kari Pollock, Ping Zhou et al. profile →
ISCT MSC committee statement on the US FDA approval of allogenic bone-marrow mesenchymal stromal cells

2025 17 citations Katarina Le Blanc, Francesco Dazzi et al. Cytotherapy profile →

Peers

Countries citing papers authored by Jan A. Nolta

Since Specialization

Citations

This map shows the geographic impact of Jan A. Nolta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan A. Nolta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan A. Nolta more than expected).

Fields of papers citing papers by Jan A. Nolta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan A. Nolta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan A. Nolta. The network helps show where Jan A. Nolta may publish in the future.

Co-authorship network of co-authors of Jan A. Nolta

This figure shows the co-authorship network connecting the top 25 collaborators of Jan A. Nolta. A scholar is included among the top collaborators of Jan A. Nolta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan A. Nolta. Jan A. Nolta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Feasibility and safety of cellular therapy for in-utero repair of myelomeningocele (CuRe Trial): a first-in-human, phase 1, single-arm study 2026 ·The Lancet ·Diana L. Farmer, Priyadarsini Kumar, Elizabeth K. Reynolds, (unknown), (unknown), Christopher D. Pivetti, (unknown), (unknown), Jan A. Nolta, (unknown), (unknown), (unknown), (unknown)	0
2	ISCT MSC committee statement on the US FDA approval of allogenic bone-marrow mesenchymal stromal cells breakdown → 2025 ·Cytotherapy ·Katarina Le Blanc, Francesco Dazzi, Karen English, Dominique Farge, Jacques Galipeau, Edwin M. Horwitz, Nadir Kadri, Mauro Krampera, Manoj M. Lalu, Jan A. Nolta, Niketa Patel, Yufang Shi, Daniel J. Weiss, Sowmya Viswanathan	17
3	Long-Term Engraftment of Cryopreserved Human Neurons for In Vivo Disease Modeling in Neurodegenerative Disease 2025 ·Biology ·David J. Marmion, Peter Deng, (unknown), Rachel L. Lewis, Lutz Harms, (unknown), Jan A. Nolta, Jeffrey H. Kordower, Kyle D. Fink, Dustin R. Wakeman	0
4	In-situ engineering of native extracellular matrix to improve vascularization and tissue regeneration at the ischemic injury site 2024 ·Dake Hao, Lu Lu, (unknown), (unknown), Ruiwu Liu, Ping Zhou, Jan A. Nolta, Diana L. Farmer, Eric A. Kurzrock, Alyssa Panitch, Kit S. Lam, Aijun Wang	0
5	An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells (MSC) Committee perspectives on International Standards Organization/Technical Committee 276 Biobanking Standards for bone marrow-MSCs and umbilical cord tissue–derived MSCs for research purposes 2023 ·Cytotherapy ·Sowmya Viswanathan, Katarina Le Blanc, Rachele Ciccocioppo, Georges Dagher, Anthony J. Filiano, Jacques Galipeau, Mauro Krampera, (unknown), Manoj M. Lalu, Jan A. Nolta, (unknown), Yufang Shi, Karin Tarte, Daniel J. Weiss, Iván Martín	13
6	Role of MEF2C in the Endothelial Cells Derived from Human Induced Pluripotent Stem Cells 2023 ·Stem Cells ·Tao Li, (unknown), (unknown), Julian Halmai, Kewa Gao, Emily Kussmaul Gonçalves Moreno, Aijun Wang, Anthony G. Passerini, Jan A. Nolta, Ping Zhou	5
7	Applications of Plant-Made Fibroblast Growth Factor for Human Pluripotent Stem Cells 2023 ·Stem Cells and Development ·Junjing Jia, (unknown), (unknown), Asuka Nishimura, (unknown), Kazuaki Ohara, (unknown), Karen A. McDonald, Somen Nandi, John G. Albeck, Raymond L. Rodriguez, Ping Zhou, Jan A. Nolta	2
8	Combination product of dermal matrix, preconditioned human mesenchymal stem cells and timolol promotes wound healing in the porcine wound model 2022 ·Journal of Biomedical Materials Research Part B Applied Biomaterials ·Hsin‐ya Yang, Fernando A. Fierro, Daniel Yoon, (unknown), Stephanie L. Osborn, Alan V. Nguyen, Thomas R. Peavy, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Heather Stewart, Eric A. Kurzrock, Athena M. Soulika, Jan A. Nolta, R. Rivkah Isseroff	6
9	Combination product of dermal matrix, human mesenchymal stem cells, and timolol promotes diabetic wound healing in mice 2020 ·Stem Cells Translational Medicine ·Hsin‐ya Yang, Fernando A. Fierro, Michelle So, Daniel Yoon, Alan V. Nguyen, (unknown), Michelle D. Bagood, (unknown), (unknown), Heather Stewart, (unknown), Mohan R. Dasu, Thomas R. Peavy, Athena M. Soulika, Jan A. Nolta, R. Rivkah Isseroff	42
10	Exosomes Derived from Human Primed Mesenchymal Stem Cells Induce Mitosis and Potentiate Growth Factor Secretion 2019 ·Stem Cells and Development ·(unknown), (unknown), Joseph Wagner, Joseph S. Anderson, (unknown), Peter Deng, Julian Halmai, Gerhard Bauer, Kyle D. Fink, Brian Fury, Nicholas H. Perotti, Jon Walker, Kari Pollock, Michelle Apperson, (unknown), Peter C. Belafsky, D. Gregory Farwell, Maggie A. Kuhn, Jan A. Nolta, Johnathon D. Anderson	43
11	Enhancing Retention of Human Bone Marrow Mesenchymal Stem Cells with Prosurvival Factors Promotes Angiogenesis in a Mouse Model of Limb Ischemia 2018 ·Stem Cells and Development ·(unknown), (unknown), (unknown), (unknown), (unknown), Jan A. Nolta, Ping Zhou	14
12	Novel Targeted Therapy for Precursor B-Cell Acute Lymphoblastic Leukemia: Anti-CD22 Antibody-MXD3 Antisense Oligonucleotide Conjugate 2016 ·Molecular Medicine ·Noriko Satake, Connie P.M. Duong, (unknown), (unknown), Cathy Chen, (unknown), Shuling Guo, Punit P. Seth, Yueju Li, Laurel Beckett, Jong Chung, Jan A. Nolta, Nitin Nitin, Joseph M. Tuscano	32
13	Inosculation of Blood Vessels Allows Early Perfusion and Vitality of Bladder Grafts—Implications for Bioengineered Bladder Wall 2015 ·Tissue Engineering Part A ·Stephanie L. Osborn, Michelle So, (unknown), Jan A. Nolta, Eric A. Kurzrock	14
14	Intravitreal Autologous Bone Marrow CD34+ Stem Cell Therapy for Macular Degenerative Disease--A Pilot Clinical Trial 2014 ·Investigative Ophthalmology & Visual Science ·Susanna S. Park, Gerhard Bauer, Athanasios Panorgias, Robert J. Zawadzki, Mehrdad Abedi, John S. Werner, Jan A. Nolta	1
15	Lysophosphatidic acid enhances stromal cell-directed angiogenesis. 2013 ·eScholarship (California Digital Library) ·Bernard Y.K. Binder, C. Søndergaard, Jan A. Nolta, J. Kent Leach	4
16	Characterization and In Vivo Testing of Mesenchymal Stem Cells Derived from Human Embryonic Stem Cells 2011 ·Tissue Engineering Part A ·William Gruenloh, Amal Kambal, Claus S. Søndergaard, Jeannine McGee, Catherine Nacey, Stefanos Kalomoiris, Karen Pepper, Scott D. Olson, Fernando A. Fierro, Jan A. Nolta	72
17	Mesenchymal stem cells for the treatment of neurodegenerative disease 2010 ·Regenerative Medicine ·Nanette C. Joyce, Geralyn Annett, Louisa Wirthlin, Scott D. Olson, Gerhard Bauer, Jan A. Nolta	384
18	shRNA-Mediated Decreases in c-Met Levels Affect the Differentiation Potential of Human Mesenchymal Stem Cells and Reduce Their Capacity for Tissue Repair 2010 ·Tissue Engineering Part A ·Ivana Rosová, Daniel C. Link, Jan A. Nolta	9
19	Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation 2002 ·Journal of Clinical Investigation ·Emanuela Gussoni, Richard Rodney Bennett, Kristina R. Muskiewicz, Todd E. Meyerrose, Jan A. Nolta, Irene Gilgoff, James H. Stein, Yiu-mo Chan, Hart G.W. Lidov, Carsten G. Bönnemann, Arpad von Moers, Glenn E. Morris, Johan T. den Dunnen, Jeffrey S. Chamberlain, Louis M. Kunkel, Kenneth I. Weinberg	116
20	IL-7 Enhances the Responsiveness of Human T Cells That Develop in the Bone Marrow of Athymic Mice 2001 ·The Journal of Immunology ·(unknown), Mo A. Dao, Xiuli Wang, Kenneth I. Weinberg, Jan A. Nolta	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact